Evaluation and treatment of cryptorchidism: AUA guideline.
Level 5 - mechanism / opinion, no new human data
Clinical practice guideline incorporating systematic review alongside expert opinion and clinical consensus
PubMed 24857650 · doi:10.1016/j.juro.2014.05.005
What was done
A systematic review of English-language peer-reviewed literature published from 1980 through 2013 was conducted by methodologists and reference librarians, identifying 704 articles. The panel synthesized this literature, using Clinical Principles and Expert Opinions when empirical data were lacking, to develop American Urological Association (AUA) guideline statements on the history, physical examination, evaluation, and hormonal and surgical management of isolated, non-syndromic cryptorchidism.
What was found
The abstract reports no numerical data, effect sizes, or statistical metrics. Qualitative consensus recommendations include: - Imaging is not recommended prior to referral. - Referral should occur by 6 months of age. - Orchiopexy is the most successful therapy to relocate the testis to the scrotum. - Hormonal therapy is not recommended. - Scrotal repositioning may reduce but does not eliminate long-term risks of infertility and testicular cancer.
Why it matters
This guideline clarifies standard clinical practice by discouraging routine pre-referral imaging and ineffective hormonal treatments, establishing early referral by 6 months of age for surgical correction.
Limits
The abstract provides no quantitative data or outcome statistics. Guideline statements relied partly on expert opinion where published evidence was insufficient, and the evidence search was restricted to English-language publications.
Cited by
- supports Cryptorchidism (undescended testicles) is associated with increased risks of male infertility and testicular cancer.